__________ (NASDAQ:AAAP) Files An 8-K Other Events
Item 8.01. Other Events.
On January 20, 2017, Pattern Energy Group Inc. issued a press
release announcing that it priced its offering of $350 million
aggregate principal amount of its 5.875% senior notes due 2024 in
a private offering to qualified institutional buyers to Rule 144A
under the Securities Act of 1933, as amended (the Securities
Act), and to certain non-U.S. persons in accordance with
Regulation S under the Securities Act. A copy of the press
release is attached as Exhibit 99.1 to this Current Report on
Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Press Release issued by Pattern Energy Group Inc. dated
January 20, 2017, titled Pattern Energy Announces Pricing of
Offering of Senior Notes
About __________ (NASDAQ:AAAP)
Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. It is engaged in developing its therapeutic candidate, Lutathera, which is a compound for the treatment of neuro endocrine tumors (NETs). It has a portfolio of approximately six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology and neurology. Its products in clinical development include Lutathera, Somakit and Annexin V-128. Its commercial products include Gluscan/Gluscan 500/Barnascan, IASOflu, IASOdopa, DOPAVIEW, IASOcholine, AAACholine, MIBITEC/Adamibi and Leukokit. __________ (NASDAQ:AAAP) Recent Trading Information
__________ (NASDAQ:AAAP) closed its last trading session up +0.02 at 28.49 with 36,472 shares trading hands.